1. Home
  2. VRA vs PBYI Comparison

VRA vs PBYI Comparison

Compare VRA & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.54

Market Cap

60.6M

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$5.78

Market Cap

263.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
PBYI
Founded
1982
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
263.4M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
VRA
PBYI
Price
$2.54
$5.78
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$4.00
$7.00
AVG Volume (30 Days)
1.1M
377.7K
Earning Date
12-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.87
EPS
N/A
0.74
Revenue
$324,296,000.00
$211,995,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.61
N/A
P/E Ratio
N/A
$7.75
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$2.58
52 Week High
$4.00
$6.27

Technical Indicators

Market Signals
Indicator
VRA
PBYI
Relative Strength Index (RSI) 57.05 54.93
Support Level $2.10 $5.81
Resistance Level $2.50 $6.27
Average True Range (ATR) 0.17 0.24
MACD 0.04 -0.00
Stochastic Oscillator 96.79 37.97

Price Performance

Historical Comparison
VRA
PBYI

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: